A state-of-the-art review highlights the use of multimodal imaging and AI to improve diagnosis and management of radiation-induced brain injury (RIBI).
Key Details
- 1Radiation-induced brain injury (RIBI) is a complex complication following cranial radiotherapy, impacting neurological function and quality of life.
- 2Multimodal imaging methods—including structural/functional MRI, diffusion and perfusion imaging, PET/CT, and radiomics—enhance early detection and differential diagnosis of RIBI versus tumor recurrence.
- 3AI techniques and machine learning models enable extraction of quantitative features, promising improved non-invasive diagnosis accuracy.
- 4Current interventions are shifting towards targeted, mechanism-driven therapies; Bevacizumab remains the only validated drug for radiation necrosis, while experimental approaches like stem cell therapy and neuromodulation are under study.
- 5Major challenges include lack of unified diagnostic criteria, early biomarkers, and seamless clinical integration of multimodal imaging and AI.
- 6The article calls for standardized protocols, expanded research, and multidisciplinary collaboration to achieve precision management.
Why It Matters
RIBI is an increasingly recognized complication given longer brain tumor survival, yet its diagnosis remains difficult using conventional imaging. Integrating advanced multimodal techniques and AI-driven analysis could transform early detection and precision treatment, representing a critical area for radiology and imaging AI innovation.
Source
EurekAlert
Related News
•EurekAlert
AI-Driven CT Imaging Predicts Cardiac Events in Large UK Cohort
An AI tool analyzing CCTA images can predict future cardiovascular events and death in patients with suspected stable coronary artery disease.
•EurekAlert
AI Tool from UCLA Targets Undiagnosed Alzheimer's and Diagnostic Disparity
UCLA researchers developed an AI model using EHR data to better detect undiagnosed Alzheimer's disease, especially in underrepresented groups.
•EurekAlert
AI Multimodal Models Improve Breast Cancer Recurrence Risk Prediction
Initial results from an ECOG-ACRIN and Caris Life Sciences collaboration show AI-driven multimodal models can more accurately predict recurrence risk in early-stage breast cancer.